Vanguard Asset Management’s LB Pharmaceuticals LBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$428K Buy
11,147
+607
+6% +$25.1K ﹤0.01% 2236
2026
Q2
$342K Buy
+10,540
New +$310K ﹤0.01% 2309

Other funds holding LBRX

Vanguard Asset Management's LBRX Position: Q3 2026 in Review

Vanguard Asset Management increased its LB Pharmaceuticals (LBRX) stake by 5.8% in Q3 2026, buying an estimated $25.1K and bringing the position to 11,147 shares worth $428K. The position accounts for ﹤0.01% of the portfolio, ranked #2236.

Vanguard Asset Management first reported a position in LBRX in Q2 2026 and has held it in 2 quarters since. 147 funds tracked by Wall St. Rank hold LBRX as of Q3 2026.

  • Vanguard Asset Management held 11,147 shares of LB Pharmaceuticals worth $428K as of Q3 2026.
  • Vanguard Asset Management bought 607 LB Pharmaceuticals shares in Q3 2026, an estimated $25.1K.
  • LB Pharmaceuticals made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2236 holding.
  • Vanguard Asset Management first reported a position in LB Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 147 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.